The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
Synopsis
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1734 million in 2023 and is anticipated to reach US$ 2304.7 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Pregelatinized Starch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Pregelatinized Starch.
Report Scope
The Pharmaceutical Pregelatinized Starch market size, estimations, and forecasts are provided in terms of output/shipments (K Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Pregelatinized Starch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Pregelatinized Starch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Signet
MIKEM
Nippon Starch Chemical Co.,Ltd.
Patel Chem Specialties Pvt Ltd
Roquette
SMS
Starch Asia
Universal Starch Chem Allied Ltd.
Cargill
Tate&Lyle
Visco Starch
Galam
Banpong Tapioca Flour Industrial
Crest Cellulose
DFE Pharma
Segment by Type
Fully Pregelatinized Starch
Partially Pregelatinized Starch
Segment by Application
Capsule
Tablet
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Pregelatinized Starch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Pregelatinized Starch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Pregelatinized Starch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1734 million in 2023 and is anticipated to reach US$ 2304.7 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Pregelatinized Starch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Pregelatinized Starch.
Report Scope
The Pharmaceutical Pregelatinized Starch market size, estimations, and forecasts are provided in terms of output/shipments (K Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Pregelatinized Starch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Pregelatinized Starch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Signet
MIKEM
Nippon Starch Chemical Co.,Ltd.
Patel Chem Specialties Pvt Ltd
Roquette
SMS
Starch Asia
Universal Starch Chem Allied Ltd.
Cargill
Tate&Lyle
Visco Starch
Galam
Banpong Tapioca Flour Industrial
Crest Cellulose
DFE Pharma
Segment by Type
Fully Pregelatinized Starch
Partially Pregelatinized Starch
Segment by Application
Capsule
Tablet
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Pregelatinized Starch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Pregelatinized Starch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Pregelatinized Starch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Pharmaceutical Pregelatinized Starch Market Overview
1.1 Product Definition
1.2 Pharmaceutical Pregelatinized Starch Segment by Type
1.2.1 Global Pharmaceutical Pregelatinized Starch Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Fully Pregelatinized Starch
1.2.3 Partially Pregelatinized Starch
1.3 Pharmaceutical Pregelatinized Starch Segment by Application
1.3.1 Global Pharmaceutical Pregelatinized Starch Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Capsule
1.3.3 Tablet
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Pharmaceutical Pregelatinized Starch Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Pharmaceutical Pregelatinized Starch Production Estimates and Forecasts (2019-2030)
1.4.4 Global Pharmaceutical Pregelatinized Starch Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Pregelatinized Starch Production Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Pharmaceutical Pregelatinized Starch, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharmaceutical Pregelatinized Starch Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Date of Enter into This Industry
2.9 Pharmaceutical Pregelatinized Starch Market Competitive Situation and Trends
2.9.1 Pharmaceutical Pregelatinized Starch Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Pregelatinized Starch Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Pregelatinized Starch Production by Region
3.1 Global Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Pharmaceutical Pregelatinized Starch Production Value by Region (2019-2030)
3.2.1 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Pharmaceutical Pregelatinized Starch by Region (2025-2030)
3.3 Global Pharmaceutical Pregelatinized Starch Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Pharmaceutical Pregelatinized Starch Production by Region (2019-2030)
3.4.1 Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Pharmaceutical Pregelatinized Starch by Region (2025-2030)
3.5 Global Pharmaceutical Pregelatinized Starch Market Price Analysis by Region (2019-2024)
3.6 Global Pharmaceutical Pregelatinized Starch Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2019-2030)
4 Pharmaceutical Pregelatinized Starch Consumption by Region
4.1 Global Pharmaceutical Pregelatinized Starch Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Pharmaceutical Pregelatinized Starch Consumption by Region (2019-2030)
4.2.1 Global Pharmaceutical Pregelatinized Starch Consumption by Region (2019-2024)
4.2.2 Global Pharmaceutical Pregelatinized Starch Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Pharmaceutical Pregelatinized Starch Production by Type (2019-2030)
5.1.1 Global Pharmaceutical Pregelatinized Starch Production by Type (2019-2024)
5.1.2 Global Pharmaceutical Pregelatinized Starch Production by Type (2025-2030)
5.1.3 Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2019-2030)
5.2 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2019-2030)
5.2.1 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2019-2024)
5.2.2 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2025-2030)
5.2.3 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Type (2019-2030)
5.3 Global Pharmaceutical Pregelatinized Starch Price by Type (2019-2030)
6 Segment by Application
6.1 Global Pharmaceutical Pregelatinized Starch Production by Application (2019-2030)
6.1.1 Global Pharmaceutical Pregelatinized Starch Production by Application (2019-2024)
6.1.2 Global Pharmaceutical Pregelatinized Starch Production by Application (2025-2030)
6.1.3 Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2019-2030)
6.2 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2019-2030)
6.2.1 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2019-2024)
6.2.2 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2025-2030)
6.2.3 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Application (2019-2030)
6.3 Global Pharmaceutical Pregelatinized Starch Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Signet
7.1.1 Signet Pharmaceutical Pregelatinized Starch Corporation Information
7.1.2 Signet Pharmaceutical Pregelatinized Starch Product Portfolio
7.1.3 Signet Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Signet Main Business and Markets Served
7.1.5 Signet Recent Developments/Updates
7.2 MIKEM
7.2.1 MIKEM Pharmaceutical Pregelatinized Starch Corporation Information
7.2.2 MIKEM Pharmaceutical Pregelatinized Starch Product Portfolio
7.2.3 MIKEM Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.2.4 MIKEM Main Business and Markets Served
7.2.5 MIKEM Recent Developments/Updates
7.3 Nippon Starch Chemical Co.,Ltd.
7.3.1 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Corporation Information
7.3.2 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Portfolio
7.3.3 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Nippon Starch Chemical Co.,Ltd. Main Business and Markets Served
7.3.5 Nippon Starch Chemical Co.,Ltd. Recent Developments/Updates
7.4 Patel Chem Specialties Pvt Ltd
7.4.1 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Corporation Information
7.4.2 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Portfolio
7.4.3 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Patel Chem Specialties Pvt Ltd Main Business and Markets Served
7.4.5 Patel Chem Specialties Pvt Ltd Recent Developments/Updates
7.5 Roquette
7.5.1 Roquette Pharmaceutical Pregelatinized Starch Corporation Information
7.5.2 Roquette Pharmaceutical Pregelatinized Starch Product Portfolio
7.5.3 Roquette Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Roquette Main Business and Markets Served
7.5.5 Roquette Recent Developments/Updates
7.6 SMS
7.6.1 SMS Pharmaceutical Pregelatinized Starch Corporation Information
7.6.2 SMS Pharmaceutical Pregelatinized Starch Product Portfolio
7.6.3 SMS Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.6.4 SMS Main Business and Markets Served
7.6.5 SMS Recent Developments/Updates
7.7 Starch Asia
7.7.1 Starch Asia Pharmaceutical Pregelatinized Starch Corporation Information
7.7.2 Starch Asia Pharmaceutical Pregelatinized Starch Product Portfolio
7.7.3 Starch Asia Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Starch Asia Main Business and Markets Served
7.7.5 Starch Asia Recent Developments/Updates
7.8 Universal Starch Chem Allied Ltd.
7.8.1 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Corporation Information
7.8.2 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Portfolio
7.8.3 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Universal Starch Chem Allied Ltd. Main Business and Markets Served
7.7.5 Universal Starch Chem Allied Ltd. Recent Developments/Updates
7.9 Cargill
7.9.1 Cargill Pharmaceutical Pregelatinized Starch Corporation Information
7.9.2 Cargill Pharmaceutical Pregelatinized Starch Product Portfolio
7.9.3 Cargill Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Cargill Main Business and Markets Served
7.9.5 Cargill Recent Developments/Updates
7.10 Tate&Lyle
7.10.1 Tate&Lyle Pharmaceutical Pregelatinized Starch Corporation Information
7.10.2 Tate&Lyle Pharmaceutical Pregelatinized Starch Product Portfolio
7.10.3 Tate&Lyle Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Tate&Lyle Main Business and Markets Served
7.10.5 Tate&Lyle Recent Developments/Updates
7.11 Visco Starch
7.11.1 Visco Starch Pharmaceutical Pregelatinized Starch Corporation Information
7.11.2 Visco Starch Pharmaceutical Pregelatinized Starch Product Portfolio
7.11.3 Visco Starch Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Visco Starch Main Business and Markets Served
7.11.5 Visco Starch Recent Developments/Updates
7.12 Galam
7.12.1 Galam Pharmaceutical Pregelatinized Starch Corporation Information
7.12.2 Galam Pharmaceutical Pregelatinized Starch Product Portfolio
7.12.3 Galam Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Galam Main Business and Markets Served
7.12.5 Galam Recent Developments/Updates
7.13 Banpong Tapioca Flour Industrial
7.13.1 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Corporation Information
7.13.2 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Portfolio
7.13.3 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Banpong Tapioca Flour Industrial Main Business and Markets Served
7.13.5 Banpong Tapioca Flour Industrial Recent Developments/Updates
7.14 Crest Cellulose
7.14.1 Crest Cellulose Pharmaceutical Pregelatinized Starch Corporation Information
7.14.2 Crest Cellulose Pharmaceutical Pregelatinized Starch Product Portfolio
7.14.3 Crest Cellulose Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Crest Cellulose Main Business and Markets Served
7.14.5 Crest Cellulose Recent Developments/Updates
7.15 DFE Pharma
7.15.1 DFE Pharma Pharmaceutical Pregelatinized Starch Corporation Information
7.15.2 DFE Pharma Pharmaceutical Pregelatinized Starch Product Portfolio
7.15.3 DFE Pharma Pharmaceutical Pregelatinized Starch Production, Value, Price and Gross Margin (2019-2024)
7.15.4 DFE Pharma Main Business and Markets Served
7.15.5 DFE Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Pregelatinized Starch Industry Chain Analysis
8.2 Pharmaceutical Pregelatinized Starch Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Pregelatinized Starch Production Mode & Process
8.4 Pharmaceutical Pregelatinized Starch Sales and Marketing
8.4.1 Pharmaceutical Pregelatinized Starch Sales Channels
8.4.2 Pharmaceutical Pregelatinized Starch Distributors
8.5 Pharmaceutical Pregelatinized Starch Customers
9 Pharmaceutical Pregelatinized Starch Market Dynamics
9.1 Pharmaceutical Pregelatinized Starch Industry Trends
9.2 Pharmaceutical Pregelatinized Starch Market Drivers
9.3 Pharmaceutical Pregelatinized Starch Market Challenges
9.4 Pharmaceutical Pregelatinized Starch Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharmaceutical Pregelatinized Starch Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Pharmaceutical Pregelatinized Starch Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Pharmaceutical Pregelatinized Starch Production Capacity (K Tons) by Manufacturers in 2023
Table 4. Global Pharmaceutical Pregelatinized Starch Production by Manufacturers (2019-2024) & (K Tons)
Table 5. Global Pharmaceutical Pregelatinized Starch Production Market Share by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Pregelatinized Starch Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Pharmaceutical Pregelatinized Starch Production Value Share by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical Pregelatinized Starch Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Pregelatinized Starch as of 2023)
Table 10. Global Market Pharmaceutical Pregelatinized Starch Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Pharmaceutical Pregelatinized Starch Production Sites and Area Served
Table 12. Manufacturers Pharmaceutical Pregelatinized Starch Product Types
Table 13. Global Pharmaceutical Pregelatinized Starch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Pharmaceutical Pregelatinized Starch Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Region (2019-2024)
Table 18. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Pharmaceutical Pregelatinized Starch Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Pharmaceutical Pregelatinized Starch Production Comparison by Region: 2019 VS 2023 VS 2030 (K Tons)
Table 21. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Region (2019-2024)
Table 22. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2019-2024)
Table 23. Global Pharmaceutical Pregelatinized Starch Production (K Tons) Forecast by Region (2025-2030)
Table 24. Global Pharmaceutical Pregelatinized Starch Production Market Share Forecast by Region (2025-2030)
Table 25. Global Pharmaceutical Pregelatinized Starch Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Pharmaceutical Pregelatinized Starch Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K Tons)
Table 28. Global Pharmaceutical Pregelatinized Starch Consumption by Region (2019-2024) & (K Tons)
Table 29. Global Pharmaceutical Pregelatinized Starch Consumption Market Share by Region (2019-2024)
Table 30. Global Pharmaceutical Pregelatinized Starch Forecasted Consumption by Region (2025-2030) & (K Tons)
Table 31. Global Pharmaceutical Pregelatinized Starch Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Tons)
Table 33. North America Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2024) & (K Tons)
Table 34. North America Pharmaceutical Pregelatinized Starch Consumption by Country (2025-2030) & (K Tons)
Table 35. Europe Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Tons)
Table 36. Europe Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2024) & (K Tons)
Table 37. Europe Pharmaceutical Pregelatinized Starch Consumption by Country (2025-2030) & (K Tons)
Table 38. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K Tons)
Table 39. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (2019-2024) & (K Tons)
Table 40. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (2025-2030) & (K Tons)
Table 41. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Tons)
Table 42. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (2019-2024) & (K Tons)
Table 43. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (2025-2030) & (K Tons)
Table 44. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Type (2019-2024)
Table 45. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Type (2025-2030)
Table 46. Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2019-2024)
Table 47. Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2025-2030)
Table 48. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Pharmaceutical Pregelatinized Starch Production Value Share by Type (2019-2024)
Table 51. Global Pharmaceutical Pregelatinized Starch Production Value Share by Type (2025-2030)
Table 52. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2019-2024)
Table 53. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2025-2030)
Table 54. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Application (2019-2024)
Table 55. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Application (2025-2030)
Table 56. Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2019-2024)
Table 57. Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2025-2030)
Table 58. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Pharmaceutical Pregelatinized Starch Production Value Share by Application (2019-2024)
Table 61. Global Pharmaceutical Pregelatinized Starch Production Value Share by Application (2025-2030)
Table 62. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2019-2024)
Table 63. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2025-2030)
Table 64. Signet Pharmaceutical Pregelatinized Starch Corporation Information
Table 65. Signet Specification and Application
Table 66. Signet Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Signet Main Business and Markets Served
Table 68. Signet Recent Developments/Updates
Table 69. MIKEM Pharmaceutical Pregelatinized Starch Corporation Information
Table 70. MIKEM Specification and Application
Table 71. MIKEM Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. MIKEM Main Business and Markets Served
Table 73. MIKEM Recent Developments/Updates
Table 74. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Corporation Information
Table 75. Nippon Starch Chemical Co.,Ltd. Specification and Application
Table 76. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Nippon Starch Chemical Co.,Ltd. Main Business and Markets Served
Table 78. Nippon Starch Chemical Co.,Ltd. Recent Developments/Updates
Table 79. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Corporation Information
Table 80. Patel Chem Specialties Pvt Ltd Specification and Application
Table 81. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Patel Chem Specialties Pvt Ltd Main Business and Markets Served
Table 83. Patel Chem Specialties Pvt Ltd Recent Developments/Updates
Table 84. Roquette Pharmaceutical Pregelatinized Starch Corporation Information
Table 85. Roquette Specification and Application
Table 86. Roquette Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Roquette Main Business and Markets Served
Table 88. Roquette Recent Developments/Updates
Table 89. SMS Pharmaceutical Pregelatinized Starch Corporation Information
Table 90. SMS Specification and Application
Table 91. SMS Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. SMS Main Business and Markets Served
Table 93. SMS Recent Developments/Updates
Table 94. Starch Asia Pharmaceutical Pregelatinized Starch Corporation Information
Table 95. Starch Asia Specification and Application
Table 96. Starch Asia Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Starch Asia Main Business and Markets Served
Table 98. Starch Asia Recent Developments/Updates
Table 99. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Corporation Information
Table 100. Universal Starch Chem Allied Ltd. Specification and Application
Table 101. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Universal Starch Chem Allied Ltd. Main Business and Markets Served
Table 103. Universal Starch Chem Allied Ltd. Recent Developments/Updates
Table 104. Cargill Pharmaceutical Pregelatinized Starch Corporation Information
Table 105. Cargill Specification and Application
Table 106. Cargill Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Cargill Main Business and Markets Served
Table 108. Cargill Recent Developments/Updates
Table 109. Tate&Lyle Pharmaceutical Pregelatinized Starch Corporation Information
Table 110. Tate&Lyle Specification and Application
Table 111. Tate&Lyle Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Tate&Lyle Main Business and Markets Served
Table 113. Tate&Lyle Recent Developments/Updates
Table 114. Visco Starch Pharmaceutical Pregelatinized Starch Corporation Information
Table 115. Visco Starch Specification and Application
Table 116. Visco Starch Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Visco Starch Main Business and Markets Served
Table 118. Visco Starch Recent Developments/Updates
Table 119. Galam Pharmaceutical Pregelatinized Starch Corporation Information
Table 120. Galam Specification and Application
Table 121. Galam Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Galam Main Business and Markets Served
Table 123. Galam Recent Developments/Updates
Table 124. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Corporation Information
Table 125. Banpong Tapioca Flour Industrial Specification and Application
Table 126. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Banpong Tapioca Flour Industrial Main Business and Markets Served
Table 128. Banpong Tapioca Flour Industrial Recent Developments/Updates
Table 129. Crest Cellulose Pharmaceutical Pregelatinized Starch Corporation Information
Table 130. Crest Cellulose Specification and Application
Table 131. Crest Cellulose Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. Crest Cellulose Main Business and Markets Served
Table 133. Crest Cellulose Recent Developments/Updates
Table 134. Crest Cellulose Pharmaceutical Pregelatinized Starch Corporation Information
Table 135. DFE Pharma Specification and Application
Table 136. DFE Pharma Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. DFE Pharma Main Business and Markets Served
Table 138. DFE Pharma Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Pharmaceutical Pregelatinized Starch Distributors List
Table 142. Pharmaceutical Pregelatinized Starch Customers List
Table 143. Pharmaceutical Pregelatinized Starch Market Trends
Table 144. Pharmaceutical Pregelatinized Starch Market Drivers
Table 145. Pharmaceutical Pregelatinized Starch Market Challenges
Table 146. Pharmaceutical Pregelatinized Starch Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharmaceutical Pregelatinized Starch
Figure 2. Global Pharmaceutical Pregelatinized Starch Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Pharmaceutical Pregelatinized Starch Market Share by Type: 2023 VS 2030
Figure 4. Fully Pregelatinized Starch Product Picture
Figure 5. Partially Pregelatinized Starch Product Picture
Figure 6. Global Pharmaceutical Pregelatinized Starch Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Pharmaceutical Pregelatinized Starch Market Share by Application: 2023 VS 2030
Figure 8. Capsule
Figure 9. Tablet
Figure 10. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) & (2019-2030)
Figure 12. Global Pharmaceutical Pregelatinized Starch Production Capacity (K Tons) & (2019-2030)
Figure 13. Global Pharmaceutical Pregelatinized Starch Production (K Tons) & (2019-2030)
Figure 14. Global Pharmaceutical Pregelatinized Starch Average Price (US$/Ton) & (2019-2030)
Figure 15. Pharmaceutical Pregelatinized Starch Report Years Considered
Figure 16. Pharmaceutical Pregelatinized Starch Production Share by Manufacturers in 2023
Figure 17. Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Pregelatinized Starch Revenue in 2023
Figure 19. Global Pharmaceutical Pregelatinized Starch Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Pharmaceutical Pregelatinized Starch Production Comparison by Region: 2019 VS 2023 VS 2030 (K Tons)
Figure 22. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Japan Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Pharmaceutical Pregelatinized Starch Consumption by Region: 2019 VS 2023 VS 2030 (K Tons)
Figure 28. Global Pharmaceutical Pregelatinized Starch Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 30. North America Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2019-2030)
Figure 31. Canada Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 32. U.S. Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 33. Europe Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 34. Europe Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2019-2030)
Figure 35. Germany Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 36. France Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 37. U.K. Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 38. Italy Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 39. Russia Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 40. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 41. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Market Share by Regions (2019-2030)
Figure 42. China Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 43. Japan Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 44. South Korea Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 45. China Taiwan Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 46. Southeast Asia Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 47. India Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 48. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 49. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 51. Brazil Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 52. Turkey Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 53. GCC Countries Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (2019-2024) & (K Tons)
Figure 54. Global Production Market Share of Pharmaceutical Pregelatinized Starch by Type (2019-2030)
Figure 55. Global Production Value Market Share of Pharmaceutical Pregelatinized Starch by Type (2019-2030)
Figure 56. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Pharmaceutical Pregelatinized Starch by Application (2019-2030)
Figure 58. Global Production Value Market Share of Pharmaceutical Pregelatinized Starch by Application (2019-2030)
Figure 59. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2019-2030)
Figure 60. Pharmaceutical Pregelatinized Starch Value Chain
Figure 61. Pharmaceutical Pregelatinized Starch Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
